The German Medical Association calls on the federal government to fully cover health insurance contributions for citizens’ benefit recipients to stabilize the healthcare system.
Pfizer is acquiring Metsera for $4.9 billion, securing a portfolio of next-generation obesity therapies. The deal could reshape the market for cardiometabolic diseases.
With the new brand “Der ÖGD – Protects. Helps. Explains.”, federal and state governments highlight the indispensable work of public health offices. A nationwide campaign informs citizens.
The new Bonsai OTC Category Spotlight shows: Cold remedies are the clear No. 1 in German pharmacies – and pharmacists’ enjoyment of consultations is rising.
On October 31, 2024, the “Golden Leaf Gala” will premiere in Cologne – an exclusive event putting medical cannabis in the spotlight and uniting industry pioneers.
On September 17, 2025, Expopharm opens its doors in Düsseldorf: Europe’s largest pharmacy industry gathering with top exhibitors, 200 speakers and practice-oriented sessions.
COMPRIX 2026 has started: From November 3, creative healthcare projects can be submitted – now also in the brand-new “Health Design” category.
The EIB provides Fresenius with a €400 million loan to strengthen research, innovation, and biosimilar production in Europe.
Starting October 15, 2025, pharmacies will permanently offer flu vaccinations. Pharma Germany sees this as a key step for prevention and public health.
The new bvik study reveals: B2B marketing budgets are declining in 2025 for the first time in five years. Still, companies are focusing on lead generation, digital infrastructure, and marketing automation.
Despite economic uncertainties, the pharmaceutical sector remains one of Germany’s most attractive employers. A recent survey shows: 76.5% rate the industry as attractive.
AstraZeneca Germany has launched a new employer branding campaign where employees openly share how their work makes a difference for them and for society.
expopharm 2025 in Düsseldorf features numerous events with ABDA participation – from pharmaceutical services to key questions on the future of healthcare.
Eli Lilly is investing $2.5 billion in a new production site in Alzey, Germany. The facility will create up to 1,000 new jobs in the pharmaceutical industry.
Personal care is more than cosmetics – it’s becoming a global foundation for health, well-being, and prevention. A new study reveals how routines are changing lives.
100 days after its launch, Germany’s electronic health record (ePA) is only used by a small number of insured persons. Technical barriers and lack of information slow down progress.
Norgine has successfully completed the acquisition of Theravia, strengthening its rare disease portfolio and market presence across Europe and ANZ.
The DKV Report 2025 reveals alarming trends in Germany’s health behavior: only 2% of the population meets all the benchmarks for a healthy lifestyle. Lack of exercise, chronic stress and excessive sitting are major concerns.
Starting in August 2025, sebamed presents a modern packaging redesign that combines transparency, medical expertise, and sustainability – with the same trusted quality.
A new study shows that even primary school children are under significant stress. Academic pressure, bullying, and media use are major contributors.
